TY  - JOUR
AU  - Canet, Luz M
AU  - Sanchez-Maldonado, Jose M
AU  - Caliz, Rafael
AU  - Rodriguez-Ramos, Ana
AU  - Lupiañez, Carmen B
AU  - Canhão, Helena
AU  - Martinez-Bueno, Manuel
AU  - Escudero, Alejandro
AU  - Segura-Catena, Juana
AU  - Sorensen, Signe B
AU  - Hetland, Merete L
AU  - Soto-Pino, María Jose
AU  - Ferrer, Miguel A
AU  - Garcia, Antonio
AU  - Glintborg, Bente
AU  - Filipescu, Ileana
AU  - Perez-Pampin, Eva
AU  - Gonzalez-Utrilla, Alfonso
AU  - Nevot, Miguel Angel López
AU  - Conesa-Zamora, Pablo
AU  - Broeder, Alfons den
AU  - De Vita, Salvatore
AU  - Jacobsen, Sven Erik Hobe
AU  - Collantes-Estevez, Eduardo
AU  - Quartuccio, Luca
AU  - Canzian, Federico
AU  - Fonseca, João E
AU  - Coenen, Marieke J H
AU  - Andersen, Vibeke
AU  - Sainz, Juan
PY  - 2018
DO  - 10.1038/s41397-018-0057-x
UR  - http://hdl.handle.net/10668/13031
T2  - The pharmacogenomics journal
AB  - The aim of this case-control study was to evaluate whether 47 single-nucleotide polymorphisms (SNPs) in steroid hormone-related genes are associated with the risk of RA and anti-TNF drug response. We conducted a case-control study in 3 European...
LA  - en
PB  - Nature Publishing Group
KW  - Antirheumatic agents
KW  - Arthritis, rheumatoid
KW  - Case-control studies
KW  - Cytochrome P-450 CYP2C9
KW  - Cytochrome P-450 CYP3A
KW  - Estrogen receptor beta
KW  - Female
KW  - Gonadal steroid hormones
KW  - Haplotypes
KW  - Humans
KW  - Male
KW  - Metabolic detoxication, phase I
KW  - Polymorphism, single nucleotide
KW  - Tumor necrosisfactor-alpha
KW  - Ubiquitin-protein ligases
TI  - Polymorphisms at phase I-metabolizing enzyme and hormone receptor loci influence the response to anti-TNF therapy in rheumatoid arthritis patients.
TY  - Research article
VL  - 19
ER  -